BioCentury | Aug 17, 2019
Financial News

Aug. 16 Financial Quick Takes: Trio of IPO filings; plus Bellicum, Generex

...to use the funds to advance Phase III testing for its mucositis candidate Validive clonidine lauriad...
BioCentury | Nov 2, 2017
Company News

Monopar gets rights to Onxeo's Validive

...S.A. (Euronext:ONXEO; CSE:ONXEO) granted Monopar Therapeutics Inc. (Northbrook, Ill.) exclusive, worldwide rights to Validive clonidine lauriad...
...study. Onxeo S.A. (Euronext:ONXEO; CSE:ONXEO), Paris, France Monopar Therapeutics Inc., Northbrook, Ill. Business: Other Chris Lieu Clonidine Lauriad Validive Monopar...
BioCentury | Oct 19, 2015
Company News

Dara BioSciences, Onxeo sales and marketing update

...Dara launched Oravig miconazole in the U.S. to treat oral candidiasis. Dara has U.S. rights to...
...U.S. to treat oral candidiasis. Dara has U.S. rights to the mucoadhesive buccal tablet of miconazole...
...the oncology market. The wholesale acquisition cost (WAC) of one 50 mg tablet is $54.43. Oravig...
BioCentury | Jul 27, 2015
Company News

Dara BioSciences, Midatech Pharma deal

...tied to sales milestones for oral mucositis drug Gelclair povidone and oropharyngeal candidiasis drug Oravig miconazole...
...half. Dara has rights to Gelclair from Helsinn Healthcare S.A. (Lugano, Switzerland) and rights to Oravig...
BioCentury | Jul 20, 2015
Clinical News

Clonidine Lauriad: Phase II final data

...Society of Clinical Oncology meeting in Chicago. Onxeo S.A. (Euronext:ONXEO; CSE:ONXEO), Paris, France Product: Clonidine Lauriad...
BioCentury | Mar 16, 2015
Company News

Onxeo, Dara BioSciences deal

...Onxeo granted Dara exclusive rights in the U.S. to commercialize Oravig miconazole, which is approved to...
...as part of a postmarketing commitment, which may provide for an expanded indication. Onxeo considered Oravig...
...partnered with Mission Pharmacal Co. (San Antonio, Texas) to co-promote the mucoadhesive buccal tablet of miconazole...
BioCentury | Mar 2, 2015
Strategy

Sosei finds its R&D engine

...deal comprised the four preclinical programs and SO-1105 , a mucoadhesive buccal tablet of miconazole. SO-1105...
BioCentury | Nov 19, 2014
Financial News

Onxeo proposes EUR 35.4M rights offering

...to treat hepatocellular carcinoma and plans to begin a Phase III trial of Validive clonidine Lauriad...
BioCentury | Jul 21, 2014
Company News

BioAlliance, EMS deal

...BioAlliance granted EMS rights to commercialize Sitavig acyclovir Lauriad in Brazil. The mucoadhesive formulation of acyclovir...
BioCentury | May 12, 2014
Clinical News

Validive clonidine Lauriad: Completed Phase II enrollment

...patients with head and neck cancer. BioAlliance Pharma S.A. (Euronext:BIO), Paris, France Product: Validive clonidine Lauriad...
Items per page:
1 - 10 of 181